Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.25.1 (
deoxyribonuclease
)
1,471
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Binding sites for
prolactin
were identified in a plasma-membrane-enriched fraction isolated from livers of mature female rats. 125I-labelled sheep
prolactin
prepared by the lactoperoxidase procedure retained the same molecular integrity and binding affinity as the native hormone at physiological pH. The receptors bound
prolactin
from different species, whereas non-lactogenic hormones were not bound. The binding of 125I-labelled sheep
prolactin
was activated equally by bivalent and univalent cations, bivalent cations exerting their maximal effect at much lower concentrations. The association of 125I-labelled sheep
prolactin
with the receptor was a time- and temperature-dependent process. Partial dissociation was detected. The binding of 125I-labelled sheep
prolactin
was strongly influenced by pH, with an optimum observed at pH 6.5. Receptor activity was destroyed by Pronase and phospholipase C, whereas neuraminidase increased binding. Treatment of the membranes by ribonuclease and
deoxyribonuclease
did not affect the binding. Binding of 125I-labelled sheep
prolactin
was inhibited by p-chloromercuribenzoic acid, dithiothreitol and by brief exposure to high temperatures. Scatchard analysis of the binding of 125I-labelled sheep
prolactin
to receptors indicated that
prolactin
has a high affinity for its receptor. Binding of
prolactin
to liver membranes showed some properties different from those observed with mammary cells. Binding by these tissues differed in pH optimum, in effects of ions, and in response to neuraminidase.
...
PMID:Characterization of prolactin binding by membrane preparations from rat liver. 3 84